Diagnosis of diseases associated with dna transcription

Abstract

The present invention relates to the chemically modified genomic sequences of genes associated with DNA transcription to oligonucleotides and / or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA transcription which are directed against the sequence as well as to a method for ascertaining genetic and / or epigenetic parameters of genes associated with DNA transcription.

Description

[0001] The levels of observation that have been well studied by the methodological developments of recent years in molecular biology, are the genes themselves, the translation of these genes into RNA, and the resulting proteins. The question of which gene is switched on at which point in the course in of the development of an individual, and how the activation and inhibition of specific genes specific cells and tissues are controlled is correlatable to the degree and character of the methylation of the genes or of the genome. In this respect, pathogenic conditions may manifest themselves in a changed methylation pattern of individual genes or of the genome.[0002] The present invention relates to nucleic acids, oligonucleotides, PNA-oligomers and to a method for the diagnosis and / or therapy of diseases which have a connection with the genetic and / or epigenetic parameters of genes associated with DNA transcription and, in particular, with the methylation status thereof.PRIOR ART[0003]...

AI Technical Summary

Benefits of technology

Enables the accurate detection and analysis of cytosine methylation patterns in genomic DNA, facilitating the diagnosis and therapy of diseases associated with DNA transcription by providing a novel level of information on genetic and epigenetic parameters, and allowing for the identification of methylation status in specific genes and CpG dinucleotides.

Problems solved by technology

In practice, the unwanted side effects associated with cancer therapies frequently limit the treatment which could help a patient.

However, 5-methylcytosine positions cannot be identified by sequencing since 5-methylcytosine has the same base pairing behavior as cytosine.

Moreover, the epigenetic information carried by 5-methylcytosine is completely lost during PCR amplification.

However, 5-methylcytosine remains unmodified under these conditions.

However, currently only individual regions of a length of up to approximately 3000 base pairs are analyzed, a global analysis of cells for thousands of possible methylation events is not possible.

However, this method cannot reliably analyze very small fragments from small sample quantities either.

These are lost through the matrix in spite of the diffusion protection.

For nucleic acids having a multiply negatively charged backbone, the ionization process via the matrix is considerably less efficient.

Images